A Review of the Structural and Functional Features of Olmesartan Medoxomil, An Angiotensin Receptor Blocker von Mire, David E, Silfani, Tonous N, Pugsley, Michael K

Volltext

Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension von Giles, Thomas D., Oparil, Suzanne, Silfani, Tonous N., Wang, Antonia, Walker, J. Findlay

Volltext

Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals von Oparil, Suzanne, Silfani, Tonous N., Walker, J. Findlay

Volltext

Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells von Silfani, Tonous N, Freeman, Ernest J

Volltext

P-170: Use of 24-hour ambulatory blood pressure monitoring (ABPM) to assess antihypertensive efficacy: A comparison of olmesartan medoxomil (OLM) and amlodipine besylate (AML) von Marbury, Thomas C., Silfani, Tonous N.

Volltext

Use of 24-hour ambulatory blood pressure monitoring (ABPM) to assess antihypertensive efficacy: A comparison of olmesartan medoxomil (OLM) and amlodipine besylate (AML) von Marbury, Thomas C., Silfani, Tonous N.

Volltext

Kinase Regulation of Angiotensin II-Mediated Activation of Phospholipase A 2 and Growth in Vascular Smooth Muscle Cells von Silfani, Tonous N, Freeman, Ernest J

Volltext